Literature DB >> 30576755

Omalizumab effectiveness in asthma-COPD overlap: Post hoc analysis of PROSPERO.

Nicola A Hanania1, Bradley E Chipps2, Noelle M Griffin3, Bongin Yoo4, Ahmar Iqbal5, Thomas B Casale6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30576755     DOI： 10.1016/j.jaci.2018.11.032

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  9 in total

Review 1.  Asthma-chronic obstructive pulmonary disease overlap syndrome.

Authors:  Matthew F Mart; Ray Stokes Peebles
Journal:  Curr Opin Immunol       Date:  2020-11-22       Impact factor: 7.486

2.  Immunoglobulin E as a Biomarker for the Overlap of Atopic Asthma and Chronic Obstructive Pulmonary Disease.

Authors:  Craig P Hersh; Soumya Zacharia; Ram Prakash Arivu Chelvan; Lystra P Hayden; Ali Mirtar; Sara Zarei; Nirupama Putcha
Journal:  Chronic Obstr Pulm Dis       Date:  2020-01

Review 3.  Asthma-COPD Overlap Syndrome: Recent Insights and Unanswered Questions.

Authors:  Evangelia Fouka; Andriana I Papaioannou; Georgios Hillas; Paschalis Steiropoulos
Journal:  J Pers Med       Date:  2022-04-28

4.  Prediction of clinical response to omalizumab in moderate-to-severe asthma patients using the change in total serum IgE level.

Authors:  Bohou Li; Minyu Huang; Shuyu Huang; Xiaoli Zeng; Yafei Yuan; Xianru Peng; Wenqu Zhao; Yanmei Ye; Changhui Yu; Laiyu Liu; Chunquan Ou; Shaoxi Cai; Haijin Zhao
Journal:  J Thorac Dis       Date:  2020-12       Impact factor: 2.895

Review 5.  Targeted therapy in eosinophilic chronic obstructive pulmonary disease.

Authors:  Mathieu Fieldes; Chloé Bourguignon; Said Assou; Amel Nasri; Aurélie Fort; Isabelle Vachier; John De Vos; Engi Ahmed; Arnaud Bourdin
Journal:  ERJ Open Res       Date:  2021-04-12

6.  Dupilumab Treatment for Asthma: On the Road to a New Horizon Beyond Ethnic Differences?

Authors:  Yong Won Lee; Cheol-Woo Kim
Journal:  Allergy Asthma Immunol Res       Date:  2022-03       Impact factor: 5.764

Review 7.  ACO (Asthma-COPD Overlap) Is Independent from COPD, a Case in Favor: A Systematic Review.

Authors:  Naoya Fujino; Hisatoshi Sugiura
Journal:  Diagnostics (Basel)       Date:  2021-05-11

Review 8.  Evaluation and Management of Difficult-to-Treat and Severe Asthma: An Expert Opinion From the Korean Academy of Asthma, Allergy and Clinical Immunology, the Working Group on Severe Asthma.

Authors:  Byung Keun Kim; So Young Park; Ga Young Ban; Mi Ae Kim; Ji Hyang Lee; Jin An; Ji Su Shim; Youngsoo Lee; Ha Kyeong Won; Hwa Young Lee; Kyoung Hee Sohn; Sung Yoon Kang; So Young Park; Hyun Lee; Min Hye Kim; Jae Woo Kwon; Sun Young Yoon; Jae Hyun Lee; Chin Kook Rhee; Ji Yong Moon; Taehoon Lee; So Ri Kim; Jong Sook Park; Sang Heon Kim; Heung Woo Park; Jae Won Jeong; Sang Hoon Kim; Young Il Koh; Yeon Mok Oh; An Soo Jang; Kwang Ha Yoo; You Sook Cho
Journal:  Allergy Asthma Immunol Res       Date:  2020-11       Impact factor: 5.764

9.  The Response to Biologics is Better in Patients with Severe Asthma Than in Patients with Asthma-COPD Overlap Syndrome.

Authors:  Luis Pérez de Llano; David Dacal Rivas; Nuria Marina Malanda; Vicente Plaza Moral; José Antonio Gullón Blanco; Mariana Muñoz-Esquerre; Ismael García-Moguel; Rocío M Díaz Campos; Eva Martínez-Moragón; Alicia Harbenau Mena; Borja G Cosío; Alicia Padilla Galo; Carolina Cisneros Serrano
Journal:  J Asthma Allergy       Date:  2022-03-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.